Abstract
Centrosome abnormalities are hallmarks of various cancers and have been implicated in chromosome missegregation, chromosomal instability, and aneuploidy. Since genetic instability is a common feature in chronic myeloid leukemia (CML), we sought to investigate whether centrosome aberrations occur and correlate with disease stage and cytogenetic findings in CML. We examined 34 CML samples including CD34+ Ph+ cells of 18 newly diagnosed patients (chronic phase (CP)) and 16 blast crisis (BC) specimens by using a centrosome-specific antibody to pericentrin. All CP and BC samples displayed centrosome alterations as compared with corresponding CD34+ control cells. Centrosome abnormalities were detected in 29.1±5.9% of CP blasts and in 54.3±4.8% of BC blasts, but in only 2.4±1.1% of controls (P<0.0001). Additional karyotypic alterations to the t(9;22) translocation were found in only 1/18 CML-CP patients. In contrast, 11/16 (73%) CML-BC patients displayed additional karyotype alterations in 48.7% of analyzed cells, correlating with an abnormal centrosome status (P=0.0005). Our results indicate that centrosome defects are a common and early detectable feature in CML that may contribute to acquisition of chromosomal aberrations and aneuploidy. They may be considered as the driving force of disease progression and could serve as future prognostic markers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sawyers CL . Chronic myeloid leukemia. N Engl J Med 1999; 340: 1330–1340.
Calabretta B, Perrotti D . The biology of CML blast crisis. Blood 2004; 103: 4010–4022.
Hehlmann R, Berger U, Hochhaus A . Chronic myeloid leukemia – a model for oncology. Ann Hematology 2005, (in press).
Hochhaus A, Weisser A, La Rosee P, Emig M, Müller MC, Saussele S et al. Detection and quantification of residual disease in chronic myelogenous leukemia. Leukemia 2000; 14: 998–1005.
Hehlmann R, Heimpel H . Current aspects of drug therapy in Philadelphia-positive CML: correlation of tumor burden with survival. Leuk Lymphoma 1996; 22 (Suppl 1): 161–167.
Müller MC, Gattermann N, Lahaye T, Deininger MW, Berndt A, Fruehauf S et al. Dynamics of BCR–ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Leukemia 2003; 17: 2392–2400.
Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R et al. A census of human cancer genes. Nat Rev Cancer 2004; 4: 177–183.
Johansson B, Fioretos T, Mitelman F . Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 2002; 107: 76–94.
Mitelman F . Chromosomes, genes, and cancer. CA Cancer J Clin 1994; 44: 133–135.
Fabarius A, Hehlmann R, Duesberg PH . Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy. Cancer Genet Cytogenet 2003; 143: 59–72.
Duesberg P, Fabarius A, Hehlmann R . Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 2004; 56: 65–81.
Marx J . Cell biology. Do centrosome abnormalities lead to cancer? Science 2001; 292: 426–429.
Hahn WC, Weinberg RA . Rules for making human tumor cells. N Engl J Med 2002; 347: 1593–1603.
Pihan G, Doxsey SJ . Mutations and aneuploidy: co-conspirators in cancer? Cancer Cell 2003; 4: 89–94.
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20: 189–193.
Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998; 58: 3974–3985.
Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ . Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 2001; 61: 2212–2219.
Carroll PE, Okuda M, Horn HF, Biddinger P, Stambrook PJ, Gleich LL et al. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 1999; 18: 1935–1944.
Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K, Krause U et al. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer 2003; 107: 346–352.
Neben K, Giesecke C, Schweizer S, Ho AD, Krämer A . Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile. Blood 2003; 101: 289–291.
Krämer A, Schweizer S, Neben K, Giesecke C, Kalla J, Katzenberger T et al. Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma. Leukemia 2003; 17: 2207–2213.
Bornens M . Centrosome composition and microtubule anchoring mechanisms. Curr Opin Cell Biol 2002; 14: 25–34.
Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M . Proteomic characterization of the human centrosome by protein correlation profiling. Nature 2003; 426: 570–574.
Krämer A, Ho AD . Centrosome aberrations and cancer. Onkologie 2001; 24: 538–544.
Tritarelli A, Oricchio E, Ciciarello M, Mangiacasale R, Palena A, Lavia P et al. p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation. Mol Biol Cell 2004; 15: 3751–3757.
Krämer A, Lukas J, Bartek J . Checking out the centrosome. Cell Cycle 2004; 3: 1390–1393.
Nigg EA . Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001; 2: 21–32.
Hochhaus A . Cytogenetic and molecular mechanisms of resistance to imatinib. Semin Hematol 2003; 40 (Suppl 2): 69–79.
Müller MC, Hordt T, Paschka P, Merx K, La Rosee P, Hehlmann R et al. Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia. Acta Haematol 2004; 112: 30–33.
Hasford J, Pfirrmann M, Hehlmann R, Allan NC, Baccarani M, Kluin-Nelemans JC et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst 1998; 90: 850–858.
Cross NC, Feng L, Bungey J, Goldman JM . Minimal residual disease after bone marrow transplant for chronic myeloid leukaemia detected by the polymerase chain reaction. Leuk Lymphoma 1993; 11 (Suppl 1): 39–43.
Denning-Kendall P, Singha S, Bradley B, Hows J . Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions. Stem Cells 2003; 21: 61–70.
Fonatsch C, Schaadt M, Kirchner H, Diehl V . A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines. Int J Cancer 1980; 26: 749–756.
ISCN##In: Mitelman F. (ed.) Guidelines for Cancer Cytogenetics, Supplement to: International System for Human Cytogenetic Nomenclature. Basel, S. Karger, 1995.
Zimmerman WC, Sillibourne J, Rosa J, Doxsey SJ . Mitosis-specific anchoring of gamma tubulin complexes by pericentrin controls spindle organization and mitotic entry. Mol Biol Cell 2004; 15: 3642–3657.
Lingle WL, Salisbury JL . Altered centrosome structure is associated with abnormal mitoses in human breast tumors. Am J Pathol 1999; 155: 1941–1951.
Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T et al. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 2004; 64: 4800–4809.
Krämer A, Neben K, Ho AD . Centrosome replication, genomic instability and cancer. Leukemia 2002; 16: 767–775.
Nakajima T, Moriguchi M, Mitsumoto Y, Sekoguchi S, Nishikawa T, Takashima H et al. Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma. Mod Pathol 2004; 17: 722–727.
Borel F, Lohez OD, Lacroix FB, Margolis RL . Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc Natl Acad Sci USA 2002; 99: 9819–9824.
Acknowledgements
This work was Supported by the Albert und Anneliese Konanz-Stiftung Mannheim and the Forschungsfonds der Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Germany. We thank our clinical colleagues Drs P La Rosée, C Kuhn, M Schatz for collecting CML blood samples. Furthermore, we are grateful to PD Dr H Eichler (Institut für Transfusionsmedizin und Immunologie, DRK-Blutspendedienst, Mannheim, Germany) for providing umbilical cord blood samples and PD Dr C Schoch (III. Medizinische Klinik der Ludwig-Maximilians-Universität, München, Germany) for cytogenetic data. In addition, we like to thank PD Dr A Krämer (Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark) for support in centrosome immunostaining technique. We are grateful for assistance with statistical analyses to Dr C Weiss (Institut für Biostatistik, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Germany). We thank Alex D Greenwood for critically reading the manuscript and helpful discussion.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giehl, M., Fabarius, A., Frank, O. et al. Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability. Leukemia 19, 1192–1197 (2005). https://doi.org/10.1038/sj.leu.2403779
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403779
Keywords
This article is cited by
-
Tools used to assay genomic instability in cancers and cancer meiomitosis
Journal of Cell Communication and Signaling (2022)
-
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies
Cancer and Metastasis Reviews (2021)
-
DLGAP1 directs megakaryocytic growth and differentiation in an MPL dependent manner in hematopoietic cells
Biomarker Research (2019)
-
Anti-centrosome antibodies in breast cancer are the expression of autoimmunity
Immunologic Research (2014)
-
Genetic Events Other than BCR-ABL1
Current Hematologic Malignancy Reports (2014)